Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Accounts Payables (2016 - 2026)

Nrc Health's Accounts Payables history spans 16 years, with the latest figure at $1.2 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 2.09% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 2.09% decrease, with the full-year FY2025 number at $1.2 million, down 2.09% from a year prior.
  • Accounts Payables hit $1.2 million in Q4 2025 for Nrc Health, up from $1.1 million in the prior quarter.
  • Over the last five years, Accounts Payables for NRC hit a ceiling of $2.6 million in Q3 2024 and a floor of $338000.0 in Q2 2021.
  • Historically, Accounts Payables has averaged $1.4 million across 5 years, with a median of $1.2 million in 2024.
  • Biggest five-year swings in Accounts Payables: plummeted 64.68% in 2021 and later surged 390.53% in 2022.
  • Tracing NRC's Accounts Payables over 5 years: stood at $1.9 million in 2021, then tumbled by 40.66% to $1.2 million in 2022, then increased by 12.84% to $1.3 million in 2023, then decreased by 8.22% to $1.2 million in 2024, then dropped by 2.09% to $1.2 million in 2025.
  • Business Quant data shows Accounts Payables for NRC at $1.2 million in Q4 2025, $1.1 million in Q3 2025, and $1.2 million in Q2 2025.